Valneva’s chikungunya vaccine Ixchiq has been greenlit by the UK’s MHRA, allowing the single-dose vaccine to be made ...

Pfizer’s Josh Raysman, Saad Saeed, and Shanaya Deboo discuss vaccine ... is allowing pharmaceutical companies to expand their drug discovery capabilities and accelerate drug development.

Further evidence for this model for vaccine development is found ... As a consequence, many pharmaceutical companies have abandoned vaccines in favor of drugs. However, the technology is in ...

Recent vaccine ... industry. Rather, several market forces explain why pharmaceutical companies are gradually abandoning vaccines. Vaccines are used at most several times in a lifetime; drugs ...

This would reverse progress toward curbing drug shortages. AstraZeneca scrapped plans to invest $558.3 million in its vaccine ...

Thailand’s pharmaceutical industry has emerged as a key sector in the nation’s economic and healthcare landscape, reflecting robust growth and strategic ...

Eleven drugs are poised to reach blockbuster status, dramatically improving patient outcomes on a global scale.

Europe Pharmaceutical Contract Sales Outsourcing (CSO) Market – It is estimated to grow at a CAGR of 7.6% from 2022 to 2031 and reach US$ 4.6 Billion by the end of 2031.

In recent years, the pharmaceutical industry has undergone significant changes in the focus of its innovation, research and ...